Boston Massachusetts based Atea Pharmaceuticals is raising $214,999,608.00 in New Equity Investment.
Boston, MA – According to filings with the U.S. Securities and Exchange Commission, Atea Pharmaceuticals is raising $214,999,608.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Jean-Pierre Sommadossi…